Hormone replacement therapy (HRT) with drospirenone offers the additional benefit of blood pressure reduction in postmenopausal women


    loading  Checking for direct PDF access through Ovid

Abstract

The risk of cardiovascular (CV) events in postmenopausal women increases with the use of hormone replacement therapy. Drospirenone, a unique synthetic progestogen, is effective in treating menopausal symptoms and also has potent antimineralocorticoid effects that counteract the sodium- and fluid-retaining effects of estrogen. In clinical studies, drospirenone reduced blood pressure in postmenopausal women with hypertension, which could potentially lead to reductions in some CV risks

    loading  Loading Related Articles